Immune checkpoint blockade therapy for esophageal squamous cell carcinoma
J Thorac Dis
.
2018 Feb;10(2):699-702.
doi: 10.21037/jtd.2018.01.120.
Authors
Kazuto Harada
1
2
,
Dilsa Mizrak Kaya
1
,
Hideo Baba
2
,
Jaffer A Ajani
1
Affiliations
1
Department of Gastrointestinal Medical Oncology, University of Texas M. D. Anderson Cancer Center 1515 Holcombe Blvd, Houston, TX 77030, USA.
2
Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto 860-8556, Japan.
PMID:
29607137
PMCID:
PMC5864622
DOI:
10.21037/jtd.2018.01.120
No abstract available
Publication types
Editorial
Comment
Grants and funding
R01 CA138671/CA/NCI NIH HHS/United States
R01 CA172741/CA/NCI NIH HHS/United States
R21 CA127672/CA/NCI NIH HHS/United States
R21 CA129906/CA/NCI NIH HHS/United States